AI automation throughout the drug development pipeline is opening up the possibility of faster, cheaper pharmaceuticals. At 82 years old, with an aggressive form of blood cancer that six courses of ...

A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to serve everyone fairly. Only 6% of the clinical trials that backed new ...

An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The work, published ...

Biomedical research seeks to understand human physiology and disease risk, as well as myriad biological processes in humans—from the genetic level on up. Biomedical research also informs drug ...

Generative AI based on Large Language Models (LLMs), the technology behind popular tools like ChatGPT and Google Gemini, is revolutionizing various industries, including the world of drug discovery.

Interpretable AI model could offer new insights into why medicines cause certain side effects, helping to improve future drug safety predictions.

REDWOOD CITY, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc., a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today ...

Royalty Pharma plc has announced a significant $2 billion funding arrangement with Revolution Medicines, which includes up to $1.25 billion in synthetic royalty funding and up to $750 million in ...

For Kristian Cook, every pizza box he opened was another door closed on the path to overcoming obesity. “I had massive cravings for pizza,” he says. “That was my biggest downfall.” At 114 kilograms ...

An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The work, published ...